A comparative evaluation of the effects of MMR immunization and mercury doses from thimerosal-containing childhood vaccines on the population prevalence of autism.

BACKGROUND The purpose of the study was to evaluate the effects of MMR immunization and mercury from thimerosal-containing childhood vaccines on the prevalence of autism. MATERIAL/METHODS Evaluations of the Biological Surveillance Summaries of the Centers for Disease Control and Prevention (CDC), the U.S. Department of Education datasets, and the CDC's yearly live birth estimates were undertaken RESULTS It was determined that there was a close correlation between mercury doses from thimerosal--containing childhood vaccines and the prevalence of autism from the late 1980s through the mid-1990s. In contrast, there was a potential correlation between the number of primary pediatric measles-containing vaccines administered and the prevalence of autism during the 1980s. In addition, it was found that there were statistically significant odds ratios for the development of autism following increasing doses of mercury from thimerosal-containing vaccines (birth cohorts: 1985 and 1990-1995) in comparison to a baseline measurement (birth cohort: 1984). The contribution of thimerosal from childhood vaccines (>50% effect) was greater than MMR vaccine on the prevalence of autism observed in this study. CONCLUSIONS The results of this study agree with a number of previously published studies. These studies have shown that there is biological plausibility and epidemiological evidence showing a direct relationship between increasing doses of mercury from thimerosal-containing vaccines and neurodevelopmental disorders, and measles-containing vaccines and serious neurological disorders. It is recommended that thimerosal be removed from all vaccines, and additional research be undertaken to produce a MMR vaccine with an improved safety profile.

[1]  Mark F Blaxill,et al.  Reduced Levels of Mercury in First Baby Haircuts of Autistic Children , 2003, International journal of toxicology.

[2]  A Anthony,et al.  Enterocolitis in children with developmental disorders , 2000, American Journal of Gastroenterology.

[3]  W. Fraser,et al.  Prevalence of autistic spectrum disorder in children attending mainstream schools in a Welsh education authority. , 2003, Developmental medicine and child neurology.

[4]  D. Geier,et al.  Pediatric MMR Vaccination Safety , 2003 .

[5]  A. Sabrá,et al.  Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children , 1998, The Lancet.

[6]  C. Rice,et al.  Prevalence of autism in a US metropolitan area. , 2003, JAMA.

[7]  G. Evans,et al.  Acute Encephalopathy Followed by Permanent Brain Injury or Death Associated With Further Attenuated Measles Vaccines: A Review of Claims Submitted to the National Vaccine Injury Compensation Program , 1998, Pediatrics.

[8]  M. Geier.  Thimerosal in Childhood Vaccines, Neurodevelopment Disorders, and Heart Disease in the United States Finally, we analyzed data from the US , 2003 .

[9]  P. Decouflé,et al.  Prevalence of autism in a United States population: the Brick Township, New Jersey, investigation. , 2001, Pediatrics.

[10]  Mark R. Geier,et al.  A Case-Control Study of Mercury Burden in Children with Autistic Spectrum Disorders , 2003 .

[11]  V. Didenko,et al.  Thimerosal induces DNA breaks, caspase-3 activation, membrane damage, and cell death in cultured human neurons and fibroblasts. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.

[12]  Vijendra K. Singh,et al.  Abnormal Measles-Mumps-Rubella Antibodies and CNS Autoimmunity in Children with Autism , 2002, Journal of Biomedical Science.

[13]  S. Makani,et al.  Biochemical and molecular basis of thimerosal-induced apoptosis in T cells: a major role of mitochondrial pathway , 2002, Genes and Immunity.

[14]  J. L. Montagne,et al.  Measles: Reassessment of the current immunization policy , 1989 .

[15]  S Bernard,et al.  Autism: a novel form of mercury poisoning. , 2001, Medical hypotheses.

[16]  O. Sheils,et al.  Potential viral pathogenic mechanism for new variant inflammatory bowel disease , 2002, Molecular pathology : MP.

[17]  W. McMahon,et al.  The UCLA-University of Utah epidemiologic survey of autism: prevalence. , 1989, The American journal of psychiatry.

[18]  W. Fisher,et al.  A prevalence study of pervasive developmental disorders in North Dakota. , 1987, Journal of the American Academy of Child and Adolescent Psychiatry.